NDC 0069-0336

Revatio

Sildenafil Citrate

Revatio is a Oral Powder, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Sildenafil Citrate.

Product ID0069-0336_1326290c-2cdf-48ba-8ada-d89564cc7bf4
NDC0069-0336
Product TypeHuman Prescription Drug
Proprietary NameRevatio
Generic NameSildenafil Citrate
Dosage FormPowder, For Suspension
Route of AdministrationORAL
Marketing Start Date2014-06-02
Marketing CategoryNDA / NDA
Application NumberNDA203109
Labeler NamePfizer Laboratories Div Pfizer Inc
Substance NameSILDENAFIL CITRATE
Active Ingredient Strength10 mg/mL
Pharm ClassesPhosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0069-0336-21

1 BOTTLE in 1 CARTON (0069-0336-21) > 112 mL in 1 BOTTLE
Marketing Start Date2014-06-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0069-0336-21 [00069033621]

Revatio POWDER, FOR SUSPENSION
Marketing CategoryNDA
Application NumberNDA203109
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2014-06-02

Drug Details

Active Ingredients

IngredientStrength
SILDENAFIL CITRATE10 mg/mL

OpenFDA Data

SPL SET ID:f158fe10-d5dc-4432-b2c9-fc665401291b
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1307427
  • 1307431
  • 882530
  • 882527
  • 577033
  • 581645
    • UPC Code
  • 0300690338019

    • Pharmacological Class

    • Phosphodiesterase 5 Inhibitor [EPC]
    • Phosphodiesterase 5 Inhibitors [MoA]

    NDC Crossover Matching brand name "Revatio" or generic name "Sildenafil Citrate"

    NDCBrand NameGeneric Name
    0069-0336Revatiosildenafil citrate
    0069-0338Revatiosildenafil citrate
    0069-4190Revatiosildenafil citrate
    0179-0160Sildenafilsildenafil citrate
    27808-163Sildenafilsildenafil citrate
    43063-550Sildenafilsildenafil citrate
    43353-345Sildenafilsildenafil citrate
    50436-0033Sildenafilsildenafil citrate
    0904-6671SILDENAFIL CITRATESILDENAFIL CITRATE
    13668-185SILDENAFIL CITRATESILDENAFIL CITRATE
    50090-3905SILDENAFIL CITRATESILDENAFIL CITRATE
    0069-4200Viagrasildenafil citrate
    0069-4210Viagrasildenafil citrate
    0069-4220Viagrasildenafil citrate
    21695-157Viagrasildenafil citrate
    21695-158Viagrasildenafil citrate
    43063-256Viagrasildenafil citrate
    43353-764Viagrasildenafil citrate
    50090-0619Viagrasildenafil citrate

    Trademark Results [Revatio]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    REVATIO
    REVATIO
    78647984 3262541 Live/Registered
    Pfizer Inc
    2005-06-10
    REVATIO
    REVATIO
    78443802 3069332 Live/Registered
    Pfizer Inc
    2004-06-30
    REVATIO
    REVATIO
    75930879 not registered Dead/Abandoned
    Parke, Davis & Company
    2000-02-29
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.